1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical CMO Services Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharmaceutical CMO Services Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Active Pharmaceutical Ingredients (APIs)
1.4.3 Finished Dose Formulations (FDFs)
1.4.4 Packaging
1.5 Market by Application
1.5.1 Global Pharmaceutical CMO Services Market Share by Application: 2021-2026
1.5.2 Pharmaceutical Industry
1.5.3 Biotechnology Industry
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Pharmaceutical CMO Services Market
1.8.1 Global Pharmaceutical CMO Services Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical CMO Services Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Pharmaceutical CMO Services Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Pharmaceutical CMO Services Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Pharmaceutical CMO Services Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Pharmaceutical CMO Services Sales Volume Market Share by Region (2015-2020)
3.2 Global Pharmaceutical CMO Services Sales Revenue Market Share by Region (2015-2020)
3.3 North America Pharmaceutical CMO Services Sales Volume
3.3.1 North America Pharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.3.2 North America Pharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Pharmaceutical CMO Services Sales Volume
3.4.1 East Asia Pharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Pharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Pharmaceutical CMO Services Sales Volume (2015-2020)
3.5.1 Europe Pharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Pharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Pharmaceutical CMO Services Sales Volume (2015-2020)
3.6.1 South Asia Pharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Pharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Pharmaceutical CMO Services Sales Volume (2015-2020)
3.7.1 Southeast Asia Pharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Pharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Pharmaceutical CMO Services Sales Volume (2015-2020)
3.8.1 Middle East Pharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Pharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Pharmaceutical CMO Services Sales Volume (2015-2020)
3.9.1 Africa Pharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Pharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Pharmaceutical CMO Services Sales Volume (2015-2020)
3.10.1 Oceania Pharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Pharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Pharmaceutical CMO Services Sales Volume (2015-2020)
3.11.1 South America Pharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.11.2 South America Pharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Pharmaceutical CMO Services Sales Volume (2015-2020)
3.12.1 Rest of the World Pharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Pharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Pharmaceutical CMO Services Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Pharmaceutical CMO Services Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Pharmaceutical CMO Services Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Pharmaceutical CMO Services Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Pharmaceutical CMO Services Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Pharmaceutical CMO Services Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Pharmaceutical CMO Services Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Pharmaceutical CMO Services Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Pharmaceutical CMO Services Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Pharmaceutical CMO Services Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Pharmaceutical CMO Services Sales Volume Market Share by Type (2015-2020)
14.2 Global Pharmaceutical CMO Services Sales Revenue Market Share by Type (2015-2020)
14.3 Global Pharmaceutical CMO Services Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Pharmaceutical CMO Services Consumption Volume by Application (2015-2020)
15.2 Global Pharmaceutical CMO Services Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Pharmaceutical CMO Services Business
16.1 Lonza
16.1.1 Lonza Company Profile
16.1.2 Lonza Pharmaceutical CMO Services Product Specification
16.1.3 Lonza Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Delpharm
16.2.1 Delpharm Company Profile
16.2.2 Delpharm Pharmaceutical CMO Services Product Specification
16.2.3 Delpharm Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 AGC Chemicals
16.3.1 AGC Chemicals Company Profile
16.3.2 AGC Chemicals Pharmaceutical CMO Services Product Specification
16.3.3 AGC Chemicals Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Boehringer Ingelheim
16.4.1 Boehringer Ingelheim Company Profile
16.4.2 Boehringer Ingelheim Pharmaceutical CMO Services Product Specification
16.4.3 Boehringer Ingelheim Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Evonik Health Care
16.5.1 Evonik Health Care Company Profile
16.5.2 Evonik Health Care Pharmaceutical CMO Services Product Specification
16.5.3 Evonik Health Care Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 FUJIFILM Diosynth Biotechnologies
16.6.1 FUJIFILM Diosynth Biotechnologies Company Profile
16.6.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Product Specification
16.6.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Teva API
16.7.1 Teva API Company Profile
16.7.2 Teva API Pharmaceutical CMO Services Product Specification
16.7.3 Teva API Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Pfizer
16.8.1 Pfizer Company Profile
16.8.2 Pfizer Pharmaceutical CMO Services Product Specification
16.8.3 Pfizer Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 AbbVie
16.9.1 AbbVie Company Profile
16.9.2 AbbVie Pharmaceutical CMO Services Product Specification
16.9.3 AbbVie Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Recipharm
16.10.1 Recipharm Company Profile
16.10.2 Recipharm Pharmaceutical CMO Services Product Specification
16.10.3 Recipharm Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Piramal
16.11.1 Piramal Company Profile
16.11.2 Piramal Pharmaceutical CMO Services Product Specification
16.11.3 Piramal Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Catalent
16.12.1 Catalent Company Profile
16.12.2 Catalent Pharmaceutical CMO Services Product Specification
16.12.3 Catalent Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Hisun Pharmaceuticals
16.13.1 Hisun Pharmaceuticals Company Profile
16.13.2 Hisun Pharmaceuticals Pharmaceutical CMO Services Product Specification
16.13.3 Hisun Pharmaceuticals Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Patheon
16.14.1 Patheon Company Profile
16.14.2 Patheon Pharmaceutical CMO Services Product Specification
16.14.3 Patheon Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Esteve Quimica
16.15.1 Esteve Quimica Company Profile
16.15.2 Esteve Quimica Pharmaceutical CMO Services Product Specification
16.15.3 Esteve Quimica Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Fareva
16.16.1 Fareva Company Profile
16.16.2 Fareva Pharmaceutical CMO Services Product Specification
16.16.3 Fareva Pharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Pharmaceutical CMO Services Manufacturing Cost Analysis
17.1 Pharmaceutical CMO Services Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Pharmaceutical CMO Services
17.4 Pharmaceutical CMO Services Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Pharmaceutical CMO Services Distributors List
18.3 Pharmaceutical CMO Services Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Pharmaceutical CMO Services (2021-2026)
20.2 Global Forecasted Revenue of Pharmaceutical CMO Services (2021-2026)
20.3 Global Forecasted Price of Pharmaceutical CMO Services (2015-2026)
20.4 Global Forecasted Production of Pharmaceutical CMO Services by Region (2021-2026)
20.4.1 North America Pharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Pharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.3 Europe Pharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Pharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Pharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Pharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.7 Africa Pharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Pharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.9 South America Pharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Pharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Pharmaceutical CMO Services by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Pharmaceutical CMO Services by Country
21.2 East Asia Market Forecasted Consumption of Pharmaceutical CMO Services by Country
21.3 Europe Market Forecasted Consumption of Pharmaceutical CMO Services by Countriy
21.4 South Asia Forecasted Consumption of Pharmaceutical CMO Services by Country
21.5 Southeast Asia Forecasted Consumption of Pharmaceutical CMO Services by Country
21.6 Middle East Forecasted Consumption of Pharmaceutical CMO Services by Country
21.7 Africa Forecasted Consumption of Pharmaceutical CMO Services by Country
21.8 Oceania Forecasted Consumption of Pharmaceutical CMO Services by Country
21.9 South America Forecasted Consumption of Pharmaceutical CMO Services by Country
21.10 Rest of the world Forecasted Consumption of Pharmaceutical CMO Services by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer